Proton pump inhibitor use among patients at risk of peptic ulcer bleeding: a nationwide register-based study

References

• Haastrup PF, Paulsen MS, Christensen RD, et al. Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period. Aliment Pharmacol Ther. 2016;44(1):78–87.
   PubMed Web of Science ®Google Scholar
• Haastrup P, Paulsen MS, Zwisler JE, et al. Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: a nationwide observational study. Eur J Gen Pract. 2014;20(4):290–293.
   PubMed Web of Science ®Google Scholar
• Malmi H, Kautiainen H, Virta LJ, et al. Outcomes of patients hospitalized with peptic ulcer disease diagnosed in acute upper endoscopy. Eur J Gastroenterol Hepatol. 2017;29(11):1251–1257.
   PubMed Web of Science ®Google Scholar
• Petersen J, Moller Hansen J, de Muckadell OBS, et al. A model to predict the risk of aspirin/non-steroidal anti-inflammatory drugs-related upper gastrointestinal bleeding for the individual patient. Basic Clin Pharmacol Toxicol. 2020;126(5):437–443.
   PubMed Web of Science ®Google Scholar
• Lanza FL, Chan FK, Quigley EM, Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104(3):728–738.
   PubMed Web of Science ®Google Scholar
• Sharma R, Roy A, Ramos C, et al. Low adherence to national guidelines for proton-pump inhibitor prescription in patients receiving combination aspirin and anticoagulation. Therap Adv Gastroenterol. 2017;10(5):387–396.
   PubMed Web of Science ®Google Scholar
• de Jong HJ, Korevaar JC, van Dijk L, et al. Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care. BMJ Open. 2013;3(7):e003044.
   PubMed Web of Science ®Google Scholar
• Laursen SB, Hansen JM, Hallas J, et al. The excess long-term mortality in peptic ulcer bleeding is explained by nonspecific comorbidity. Scand J Gastroenterol. 2015;50(2):145–152.
   PubMed Web of Science ®Google Scholar
• Davidsen JR, Sondergaard J, Hallas J, et al. Impact of socioeconomic status on the use of inhaled corticosteroids in young adult asthmatics. Respir Med. 2011;105(5):683–690.
   PubMed Web of Science ®Google Scholar
• Koefoed MM, Sondergaard J, Christensen R, et al. Influence of socioeconomic and demographic status on spirometry testing in patients initiating medication targeting obstructive lung disease: a population-based cohort study. BMC Public Health. 2013;13:580.
   PubMed Web of Science ®Google Scholar
• Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287(5462):2398–2399.
   PubMed Web of Science ®Google Scholar
• Pedersen KM, Andersen JS, Sondergaard J. General practice and primary health care in Denmark. J Am Board Fam Med. 2012;25(Suppl 1):S34–S38.
   PubMed Web of Science ®Google Scholar
• Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7 Suppl):38–41.
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7 Suppl):30–33.
   PubMed Web of Science ®Google Scholar
• Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39(7 Suppl):103–105.
   PubMed Web of Science ®Google Scholar
• Petersson F, Baadsgaard M, Thygesen LC. Danish registers on personal labour market affiliation. Scand J Public Health. 2011;39(7 Suppl):95–98.
   PubMed Web of Science ®Google Scholar
• Jensen VM, Rasmussen AW. Danish Education Registers. Scand J Public Health. 2011;39 (7 Suppl):91–94.
   PubMed Web of Science ®Google Scholar
• Dall M, Schaffalitzky de Muckadell OB, Lassen AT, et al. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol: Off Clin Practice J Clin Gastroenterol Hepatol. 2009;7(12):1314–1321.
   PubMed Web of Science ®Google Scholar
• Lanas A, Carrera-Lasfuentes P, Arguedas Y, et al. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clin Gastroenterol Hepatol. 2015;13(5):906–912.e2.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Erlangsen A, Fedyszyn I. Danish nationwide registers for public health and health-related research. Scand J Public Health. 2015;43(4):333–339.
   PubMed Web of Science ®Google Scholar
• Rasmussen S, Jensen TH, Henriksen SL, et al. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population. Scand J Gastroenterol. 2015;50(2):162–169.
   PubMed Web of Science ®Google Scholar
• Lodrup A, Reimer C, Bytzer P. Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel. Scand J Gastroenterol. 2014;49(9):1044–1050.
   PubMed Web of Science ®Google Scholar
• Danish Health Data Authority. Available from: www.medstat.dk
   Google Scholar
• Henriksson K, From J, Stratelis G. Patient-reported adherence to coprescribed proton pump inhibitor gastroprotection in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs. Patient Prefer Adherence. 2014;8:1611–1617.
   PubMed Web of Science ®Google Scholar
• Warle-van Herwaarden MF, Koffeman AR, Valkhoff VE, et al. Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study. Br J Clin Pharmacol. 2015;80(3):589–598.
   PubMed Web of Science ®Google Scholar
• Lee HL, Chua SS, Mahadeva S. Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital. Ther Clin Risk Manag. 2016;12:1649–1657.
   PubMed Web of Science ®Google Scholar
• Targownik LE, Metge C, Roos L, et al. The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use. Am J Gastroenterol. 2007;102(5):942–950.
   PubMed Web of Science ®Google Scholar
• van Boxel OS, Hagenaars MP, Smout AJ, et al. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands. Aliment Pharmacol Ther. 2009;29(5):571–579.
   PubMed Web of Science ®Google Scholar
• Hvid-Jensen F, Nielsen RB, Pedersen L, et al. Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting. Clin Epidemiol. 2013;5:493–499.
   PubMedGoogle Scholar
• Eek F, Ostergren PO, Diderichsen F, et al. Differences in socioeconomic and gender inequalities in tobacco smoking in Denmark and Sweden; a cross sectional comparison of the equity effect of different public health policies. BMC Public Health. 2010;10:9.
   PubMed Web of Science ®Google Scholar
• Mohammed SH, Habtewold TD, Birhanu MM, et al. Neighbourhood socioeconomic status and overweight/obesity: a systematic review and meta-analysis of epidemiological studies. BMJ Open. 2019;9(11):e028238.
   PubMed Web of Science ®Google Scholar